<code id='087B0127EF'></code><style id='087B0127EF'></style>
    • <acronym id='087B0127EF'></acronym>
      <center id='087B0127EF'><center id='087B0127EF'><tfoot id='087B0127EF'></tfoot></center><abbr id='087B0127EF'><dir id='087B0127EF'><tfoot id='087B0127EF'></tfoot><noframes id='087B0127EF'>

    • <optgroup id='087B0127EF'><strike id='087B0127EF'><sup id='087B0127EF'></sup></strike><code id='087B0127EF'></code></optgroup>
        1. <b id='087B0127EF'><label id='087B0127EF'><select id='087B0127EF'><dt id='087B0127EF'><span id='087B0127EF'></span></dt></select></label></b><u id='087B0127EF'></u>
          <i id='087B0127EF'><strike id='087B0127EF'><tt id='087B0127EF'><pre id='087B0127EF'></pre></tt></strike></i>

          Wikipedia

          Wikipedia

          author:hotspot    Page View:17743

          What does it mean to a bad CEO? Can biotech endure another election year? And can you go to too many J.P. Morgan parties?

          We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. It’s our last episode of 2023, so we look back on the biggest stories of the year, discuss the best and worst CEOs in the industry, and make some reasonably informed guesses on what 2024 has in store for the drug industry.

          advertisement

          For more on what we cover, here are the year’s best CEOs; here are the worst; here’s more on biotech in 2024; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s where you can subscribe to our biotech newsletter, The Readout.

          Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

          And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

          advertisement

          explore

          Psychedelics group wrestles with new pharma identity
          Psychedelics group wrestles with new pharma identity

          OliviaGoldhill/STATDENVER—Hecouldhavebeenarockstar,areligiousicon,thewayecstaticapplausefromthousand

          read more
          Menendez indictment could see pharma lose a key ally
          Menendez indictment could see pharma lose a key ally

          Sen.BobMenendez(D-N.J.)MichaelM.Santiago/GettyImagesWASHINGTON—WithmountingcallsforembattledSen.BobM

          read more
          ChatGPT in medicine: STAT answers readers' burning questions
          ChatGPT in medicine: STAT answers readers' burning questions

          MikeReddyforSTATArtificialintelligenceisoftendescribedasablackbox:anunknowable,mysteriousforcethatop

          read more

          Intercept Pharmaceuticals sells itself for less than $1 billion

          AdobeInterceptPharmaceuticals,afirmwhosetreatmentforaprevalentliverdiseaseoncemadeitthehotteststocki